Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Impulsive, Agitated Behaviors May Be Warning Signs for Suicide

Risky behaviors such as reckless driving or sudden promiscuity, or nervous behaviors such as agitation, hand-wringing or pacing, can be signs that suicide risk may be high in depressed people, researchers report. Other warning signs may include doing things on impulse with little thought about the consequences. Depressed people with any of these symptoms...

Posted 2 days ago in New Drug Approvals

FDA Approves Repatha (evolocumab) to Treat Certain Patients with High Cholesterol

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, is approved for use in addition to diet and maximally-tolerated...

Posted 2 days ago in New Drug Approvals

FDA Approves Synjardy (empagliflozin/metformin hydrochloride) for Type 2 Diabetes

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Synjardy (empagliflozin and metformin hydrochloride) tablets, from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY), for the treatment of adults with type 2 diabetes (T2D). Synjardy is the...

Posted 3 days ago in Clinical Trials

GSK Announces NEJM Publication of Phase 3b/4 Study of Ambrisentan and Tadalafil as First-Line Combination Treatment in Patients with Pulmonary Arterial Hypertension

26 August 2015 -- GSK today announced publication of the AMBITION study, the first outcomes study to compare the safety and efficacy of investigational first-line combination therapy of Volibris® (ambrisentan) and Adcirca® (tadalafil) to first-line monotherapy of either treatment alone in treatment-naïve patients with pulmonary arterial hypertension...

Posted yesterday in Medical

FDA Approves Second Drug in New Class of Cholesterol-Lowering Medications

The U.S. Food and Drug Administration on Thursday approved a second drug that's part of a potent new class of medications that sharply cut levels of "bad" LDL cholesterol. Repatha (evolocumab), an injectable drug, works by blocking a protein that interferes with the liver's ability to remove LDL cholesterol from the blood. In July, the FDA approved...

Posted 2 days ago in Medical

How Reliable Are Medical Studies? Half of Findings Couldn't Be Replicated

Independent researchers couldn't reproduce the findings of more than half of 100 experiments previously published in three prominent psychology journals, a new review reports. This review should fuel skepticism over scientific claims, particularly if those claims are based on shaky statistics, said one of the new study's authors, Brian Nosek, a professor...

Posted yesterday in FDA Alerts

DPP-4 Inhibitors for Type 2 Diabetes: Drug Safety Communication - May Cause Severe Joint Pain

ISSUE: The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling. FDA has added a new Warning and Precaution about this risk to the labels of all medicines in this drug class, called dipeptidyl peptidase-4 (DPP-4)...

Posted 2 days ago in Medical

Even Short Bouts of Activity May Help Kids' Health

Even brief spurts of exercise may benefit children, researchers report. Their study of 28 healthy, normal-weight children found that doing three minutes of moderate-intensity walking every half hour over three hours of sitting led to lower levels of blood sugar and insulin, compared to another day when the children sat for three hours straight. On...

Posted 2 days ago in Medical

High Blood Pressure During Pregnancy May Reappear Later in Life: Study

Women with high blood pressure during pregnancy are more likely to face the same health problem later in life, a new study suggests. The researchers also said they found that the brothers and sisters of these women have a higher risk of high blood pressure later in life, and the brothers also may have a higher chance of heart disease. "The increased...

Posted yesterday in Medical

Health Highlights: Aug 28, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Bread Recalled Due to Possible Glass Fragments The risk of glass fragments from a broken light bulb has led to the recall of bread in 11 states. The recall is for Sara Lee, Kroger, Bimbo, Nature's Harvest, Great Value and L'Oven Fresh brand breads...

Read more news...

Recently added consumer and prescribing information: Addyi, Daklinza, Praluent, Odomzo, Technivie, Rexulti, Entresto, Orkambi, Viberzi, Stiolto Respimat

Posted in Blog

Have you had a medication that you could not afford lately?

If you answered yes, you probably are not alone. The cost of certain prescriptions, like those for hepatitis C, cancer and rheumatoid arthritis, have skyrocketed. Many of these special drugs cannot be accessed from a regular retail pharmacy. The patient must acquire the treatment from a “specialty pharmacy”, that may not even be in their […]

Posted in Blog

Drugs.com Reaches 500,000 Facebook Likes

Drugs.com has topped the 500,000 likes mark on our Facebook page. A huge thank you to the half million dedicated fans who follow our page, like our articles and share our links. We appreciate every single one of you. It is our aim to keep you up-to-date on all things drug related through our daily […]

Posted in Blog

Drug Shortages: Has the FDA Response Made an Impact?

Rationing of much needed medications for patients is a scary thought for me as a healthcare professional. I can understand when an orphan drug may go in short supply for a rare disease, but when commonly used medications like antibiotics and intravenous fluids become scarce, I wonder what the forces are that cause this to […]

See more blog posts or follow us on twitter.

Hide